GO
Loading...

Bristol-Myers Executive Charged With Insider Trading

FBI agents arrested Robert Ramnarine, a Bristol-Myers Squibbexecutive, on Thursday. He has been criminally charged with insider trading the call options of companies shortly before they were acquired, court papers show.

CNBC.com

Ramnarine, an assistant director for capital markets in Bristol-Myers' office in Princeton, N.J., was arrested by agents at a suburban New Jersey home this morning.

A three-count criminal complaint was unsealed this morning. According the complaint, he made more than $311,000 in illegal profit.

The insider trading in question involved several stocks, including ZymoGenetics, Pharmasset and Amylin Pharmaceuticals.

Ramnarine will have his initial court appearance later this afternoon. It is unclear whether Ramnarine has hired a lawyer for his defense.

In his position at Bristol-Myers Squibb, he was responsible for conducting due diligence concerning the pension plans of the company's acquisition targets.

No immediate response from Bristol-Myers Squibb was available.

— By CNBC's Jim Forkin. Reuters contributed to this article.

Contact U.S. News

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    Please choose a subscription
    Please enter a valid email address
    To learn more about how we use your information,
    please read our Privacy Policy.

Don't Miss

U.S. Video

  • CNBC's Mandy Drury looks back at the week's top business and financial stories. The markets hit new highs and Greece got some help. Expectations for a rate hike were pushed till later in the year.

  • Former hedge fund manager David Ganek has filed a civil rights lawsuit against Federal law enforcement officials. Insight, with Nick Brustin, attorney for David Ganek.

  • Jeff Hirsch, The Stock Trader's Almanac, and CNBC Senior Contributor Larry Kudlow discuss the psychological importance of March for the Nasdaq.